Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ake Hjalmarson

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
Lancet (London, England)|October 3, 2003
COMET: a proposed mechanism of action to explain the results and concerns about doseAke Hjalmarson, Finn Waagstein
Lancet (London, England)|December 5, 2003
The statin warsPeter Dunselman, Ake Hjalmarson, John Kjekshus, et al.
Astrobiology|December 13, 2006
Life up north: meeting report: nordic astrobiology 2006: origins & distribution of life in the universeAnthony M Poole, Tomas Hode, Axel Brandenburg, et al.
Journal of the American College of Cardiology|July 27, 2002
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)John Wikstrand, Ake Hjalmarson, Finn Waagstein, et al.
Endocrine Connections|August 21, 2014
Diabetes and ischemic heart disease: double jeopardy with regard to depressive mood and reduced quality of lifeNatasha Bergmann, Søren Ballegaard, Pernille Holmager, et al.
Plos One|May 23, 2014
The effect of daily self-measurement of pressure pain sensitivity followed by acupressure on depression and quality of life versus treatment as usual in ischemic heart disease: a randomized clinical trialNatasha Bergmann, Søren Ballegaard, Per Bech, et al.
American Heart Journal|October 18, 2003
Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HFAndrás Jánosi, Jalal K Ghali, Johan Herlitz, et al.
Journal of Autoimmunity|June 7, 2003
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathyReza Mobini, Alexander Staudt, Stephan B Felix, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
European Journal of Heart Failure|October 18, 2005
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristicsJohn Kjekshus, Peter Dunselman, Malin Blideskog, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
Lancet (London, England)|October 3, 2003
COMET: a proposed mechanism of action to explain the results and concerns about doseAke Hjalmarson, Finn Waagstein
Lancet (London, England)|December 5, 2003
The statin warsPeter Dunselman, Ake Hjalmarson, John Kjekshus, et al.
Astrobiology|December 13, 2006
Life up north: meeting report: nordic astrobiology 2006: origins & distribution of life in the universeAnthony M Poole, Tomas Hode, Axel Brandenburg, et al.
Journal of the American College of Cardiology|July 27, 2002
Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF)John Wikstrand, Ake Hjalmarson, Finn Waagstein, et al.
Endocrine Connections|August 21, 2014
Diabetes and ischemic heart disease: double jeopardy with regard to depressive mood and reduced quality of lifeNatasha Bergmann, Søren Ballegaard, Pernille Holmager, et al.
Plos One|May 23, 2014
The effect of daily self-measurement of pressure pain sensitivity followed by acupressure on depression and quality of life versus treatment as usual in ischemic heart disease: a randomized clinical trialNatasha Bergmann, Søren Ballegaard, Per Bech, et al.
American Heart Journal|October 18, 2003
Metoprolol CR/XL in postmyocardial infarction patients with chronic heart failure: experiences from MERIT-HFAndrás Jánosi, Jalal K Ghali, Johan Herlitz, et al.
Journal of Autoimmunity|June 7, 2003
Hemodynamic improvement and removal of autoantibodies against beta1-adrenergic receptor by immunoadsorption therapy in dilated cardiomyopathyReza Mobini, Alexander Staudt, Stephan B Felix, et al.
Cardiac Electrophysiology Review|January 24, 2004
How should subgroup analyses affect clinical practice? Insights from the Metoprolol Succinate Controlled-Release/Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)John Wikstrand, Hans Wedel, Jalal Ghali, et al.
European Journal of Heart Failure|October 18, 2005
A statin in the treatment of heart failure? Controlled rosuvastatin multinational study in heart failure (CORONA): study design and baseline characteristicsJohn Kjekshus, Peter Dunselman, Malin Blideskog, et al.
Pageof 3